Magali Van den Kerkhof

DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis

Charles E. Mowbray, Stéphanie Braillard, Paul A. Glossop et al. · Journal of Medicinal Chemistry · 2021 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series

Magali Van den Kerkhof, Dorien Mabille, Eric Chatelain et al. · International Journal for Parasitology Drugs and Drug Resistance · 2018 · 52 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum

Sarah Hendrickx, Magali Van den Kerkhof, Dorien Mabille et al. · PLoS neglected tropical diseases · 2017 · 41 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

Evaluation of a Pan-Leishmania Spliced-Leader RNA Detection Method in Human Blood and Experimentally Infected Syrian Golden Hamsters

Eline Eberhardt, Magali Van den Kerkhof, Dimitri Bulté et al. · Journal of Molecular Diagnostics · 2018 · 37 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +13

Miltefosine enhances the fitness of a non-virulent drug-resistant<i>Leishmania infantum</i>strain

Eline Eberhardt, Dimitri Bulté, Lieselotte Van Bockstal et al. · Journal of Antimicrobial Chemotherapy · 2018 · 25 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17